Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 41% ± 14% | |
brain | 20 studies | 42% ± 20% | |
peripheral blood | 19 studies | 52% ± 15% | |
intestine | 10 studies | 34% ± 13% | |
eye | 10 studies | 39% ± 13% | |
kidney | 9 studies | 35% ± 11% | |
liver | 6 studies | 44% ± 17% | |
lymph node | 5 studies | 49% ± 8% | |
breast | 5 studies | 37% ± 14% | |
pancreas | 4 studies | 56% ± 25% | |
bone marrow | 4 studies | 48% ± 19% | |
heart | 4 studies | 31% ± 7% | |
uterus | 4 studies | 54% ± 17% | |
prostate | 4 studies | 35% ± 9% | |
adipose | 4 studies | 40% ± 8% | |
placenta | 3 studies | 69% ± 18% | |
skin | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10699.83 | 1445 / 1445 | 100% | 104.09 | 183 / 183 |
breast | 100% | 13106.68 | 459 / 459 | 100% | 78.69 | 1115 / 1118 |
bladder | 100% | 11514.19 | 21 / 21 | 100% | 51.46 | 502 / 504 |
skin | 100% | 15054.77 | 1809 / 1809 | 100% | 67.22 | 470 / 472 |
uterus | 100% | 13371.39 | 170 / 170 | 100% | 52.02 | 457 / 459 |
lung | 100% | 14309.62 | 578 / 578 | 99% | 65.78 | 1149 / 1155 |
ovary | 100% | 12931.23 | 180 / 180 | 99% | 45.45 | 427 / 430 |
intestine | 100% | 11015.56 | 966 / 966 | 99% | 51.59 | 522 / 527 |
brain | 100% | 7528.72 | 2639 / 2642 | 99% | 39.98 | 698 / 705 |
thymus | 100% | 12018.78 | 653 / 653 | 99% | 36.61 | 596 / 605 |
stomach | 100% | 8351.32 | 359 / 359 | 98% | 64.33 | 281 / 286 |
prostate | 100% | 11951.51 | 245 / 245 | 98% | 38.36 | 493 / 502 |
pancreas | 100% | 6034.61 | 328 / 328 | 98% | 45.39 | 174 / 178 |
kidney | 100% | 8694.73 | 89 / 89 | 94% | 38.29 | 851 / 901 |
adrenal gland | 100% | 7631.17 | 258 / 258 | 87% | 21.43 | 199 / 230 |
liver | 100% | 4507.05 | 226 / 226 | 85% | 25.13 | 345 / 406 |
adipose | 100% | 12310.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 11306.13 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 50.19 | 29 / 29 |
muscle | 100% | 5942.21 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 12622.63 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.64 | 1 / 1 |
heart | 99% | 5589.60 | 849 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 59.36 | 44 / 45 |
peripheral blood | 94% | 10015.08 | 876 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 27.21 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
GO_0034063 | Biological process | stress granule assembly |
GO_0005829 | Cellular component | cytosol |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | PRRC2C |
Protein name | Protein PRRC2C Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C) Proline rich coiled-coil 2C |
Synonyms | XTP2 KIAA1096 BAT2D1 BAT2L2 |
Description | FUNCTION: Required for efficient formation of stress granules. . |
Accessions | ENST00000338920.8 [Q9Y520-4] H7C5N8 ENST00000498596.5 ENST00000647382.2 [Q9Y520-7] A0A2R8Y424 ENST00000426496.6 [Q9Y520-4] ENST00000644916.1 E7EPN9 ENST00000367742.7 A0A2R8Y7F4 A0A2R8YET2 ENST00000495585.1 ENST00000647382 Q9Y520 |